In October 2016, NICE reviewed this guidance and it is recommended to defer the review until April 2017. Please find the published review decision here.

NICE has developed medical technology guidance on Ambulight PDT.

NICE medical technologies guidance addresses specific technologies notified to NICE by manufacturers. The ‘case for adoption’ recommendations are based on the claimed advantages of introducing the specific technology compared with current management of the condition. This ‘case’ is reviewed against the evidence submitted and expert advice. If the case for adopting the technology is supported, then the technology has been found to offer advantages to patients and the NHS. The specific recommendations on individual technologies are not intended to limit use of other relevant technologies which may offer similar advantages.

Healthcare teams may want to use Ambulight PDT because it can be used to give photodynamic therapy in places other than hospitals, such as patients’ homes. It may also cause less pain than normal photodynamic therapy.  However, NICE has said that the evidence does not show that Ambulight PDT would make services more efficient, and that there is not much evidence about how well it works. NICE has said that NHS organisations should take this into account, along with other features of Ambulight PDT, when deciding whether to use it.

Is this guidance up to date?

In August 2018, NICE started the review of this guidance. To register as a stakeholder, please contact us at

Next review: 2021

Your responsibility

This guidance represents the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, healthcare professionals are expected to take this guidance fully into account. However, the guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer.

Commissioners and/or providers have a responsibility to implement the guidance, in their local context, in light of their duties to have due regard to the need to eliminate unlawful discrimination, advance equality of opportunity, and foster good relations. Nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.

Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible.

  • National Institute for Health and Care Excellence (NICE)